pLenti-EF1alpha-FLAG-HA-CAD_S1900D-HA-IRES-Neo
(Plasmid
#253786)
-
PurposepLenti lentiviral expression vector encoding FLAG- and HA-tagged human CAD bearing S1900D mutation linked to neomycin selection by an IRES under a human EF1alpha promoter.
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 253786 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepLenti-EF1alpha-DEST-IRES-Neo
-
Backbone manufacturerThis study
-
Vector typeMammalian Expression, Lentiviral
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameCAD
-
SpeciesH. sapiens (human)
-
MutationS1900D
-
Entrez GeneCAD (a.k.a. CDG1Z, DEE50, EIEE50, GATD4)
- Promoter EF1alpha
-
Tags
/ Fusion Proteins
- FLAG-HA (N terminal on insert)
- HA (C terminal on insert)
Cloning Information
- Cloning method Gateway Cloning
Resource Information
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://doi.org/10.1101/2025.07.23.666448 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pLenti-EF1alpha-FLAG-HA-CAD_S1900D-HA-IRES-Neo was a gift from Samuel McBrayer (Addgene plasmid # 253786 ; http://n2t.net/addgene:253786 ; RRID:Addgene_253786) -
For your References section:
Nitrogen metabolism profiling reveals cell state-specific pyrimidine synthesis pathway choice. Savani MR, Li B, Smith BC, Gu W, Xiao Y, Baquer G, Shipman T, Oken SS, Manoj N, Zacharias LG, Puliyappadamba VT, Stopka SA, Regan MS, Levitt MM, Edgar CK, Hicks WH, Anand S, Martin-Sandoval MS, Winston R, S Patricio J, Johnson X, Tippetts TS, Shi DD, Lemoff A, Richardson TE, Zinn PO, Solmonson A, Mathews TP, Agar NYR, DeBerardinis RJ, Abdullah KG, McBrayer SK. Nat Metab. 2026 Apr 29. doi: 10.1038/s42255-026-01520-0. 10.1038/s42255-026-01520-0 PubMed 42056505